Company intelligence / Profile preview

Oculogics

Menlo Park, California, United Statesoculogics.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Oculogics, Inc. appears to be a company involved in the life sciences or biotech sector. A recent mention lists an individual affiliated with Oculogics, Inc. as participating on the Patent Review Board at Forsyth Dental Institute and being active within R&D diligence roles[8]. However, there is no detailed public information about its product pipeline, clinical results, or specific therapeutic focus areas.

Industry: Drug Discovery Services

Drug pipeline

3 assets

AVA-101

Phase 2

Indications: Wet age-related macular degeneration

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Oculogics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oculogics.

Explore the full profile